作为NRF2目标基因的CYP4F11,促进肝细胞癌细胞生长
Jinjing Chen1, Carlee A Trindl1,2, Haofeng Ye1
1Department of Molecular Medicine, Center for Inflammation Science and Systems Medicine, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, Jupiter, Florida, USA.
核因子红色素2相关因子-2 (NRF2) 通过上调CYP4F11的作用驱动肝细胞癌 (HCC) 的生长. 准这种NRF2-CYP4F11通路可能会提高HCC治疗效率.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肝细胞癌 (HCC) 是癌症死亡的主要原因,有效治疗方法有限.
- 核因素红色素2相关因子-2 (NRF2) 途径失调在HCC中很常见,促进瘤的进展.
- 对于HCC管理,迫切需要新的治疗目标.
研究的目的:
- 在HCC中确定新的治疗点.
- 研究NRF2在HCC进展中的作用.
- 探索CYP4F11在HCC中的功能意义.
主要方法:
- 在HCC患者队列中的基因表达分析.
- 鉴定NRF2目标基因.
- 在体外研究HCC细胞系以评估CYP4F11功能.
- 对NRF2抑制和索拉芬尼布联合治疗的评估.
主要成果:
- 已确定CYP4F11为直接NRF2点基因,在HCC中升调.
- 增加的CYP4F11表达与HCC中NRF2通路激活相关.
- CYP4F11促进HCC细胞的增殖和存活.
- 降低CYP4F11的调节抑制了HCC的生长,并增强了索拉芬尼的敏感性.
结论:
- NRF2-CYP4F11轴是HCC进展的关键驱动力.
- CYP4F11是HCC的潜在治疗标.
- 准NRF2-CYP4F11通路可以增强当前的HCC疗法,如 sorafenib.
更多相关视频
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
相关概念视频
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Abnormal Proliferation
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Inhibition of Cdk Activity
